Health Care Down After Mixed Earnings — Health Care Roundup

Health-care companies fell after mixed earnings.

Shares of hospital chain HCA slid after costs associated with treating uninsured patients offset revenue growth.

Shares of Swiss drug maker Novartis rose after a strong third-quarter earnings report.

Health insurers were mixed after Centene raised its growth projections for the third time as it controlled medical costs.

British drug maker GSK expects to nearly double the number of cancer medicines it is testing in clinical trials next year, according to one of its top scientists, highlighting how the company's dealmaking spree is filling its drug pipeline.

 

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

October 27, 2026 17:38 ET (21:38 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center